Healthcare Approval Gate Cost Per Case | Moring
Cost per case is where a healthcare payor approval gate meets its own economics: administrative work already consumes 34 percent of clinical time, US health spending reached 17.3 percent of GDP in 2022, and governance software itself costs USD 40,000 to USD 500,000. The gate should require per-case cost evidence at approval and monitor variance against the approved envelope in production.
Short answer
Cost per case is where a healthcare payor approval gate meets its own economics: administrative work already consumes 34 percent of clinical time, US health spending reached 17.3 percent of GDP in 2022, and governance software itself costs USD 40,000 to USD 500,000. The gate should require per-case cost evidence at approval and monitor variance against the approved envelope in production.
How it works
Cost per case is the unit where a healthcare payor approval gate meets its own economics, because prior authorization is both the costliest workflow to automate and the one where the gate is least optional. Physicians and their staff spend an average of 34 percent of clinical time on administrative work rather than on patients, and prior authorization is one of the heaviest contributors, which explains why automation proposals reach payor executives constantly and why each one needs a gate decision.
The macro context sharpens the scrutiny. US health care expenditures reached 17.3 percent of gross domestic product in 2022, nearly three times the share spent in 1970, and analysis of AI's cost potential argues the trajectory cannot continue without harming family finances and public budgets. A payor evaluating an agent that touches authorization decisions is therefore operating under sector-wide cost pressure, and the approval gate is where the claimed savings get tested against the cost of governing them.
Per-case arithmetic has two sides. Vendor-facing analysis prices custom healthcare governance software between USD 40,000 and USD 500,000 depending on integrations, security, monitoring, and scale, and that investment amortizes across the cases the gate reviews. On the other side, an approved automation changes the cost of each authorization decision: human review minutes, coordination overhead, appeal handling, and error rework. The gate should require both sides on the record before approval, so cost-per-case claims are examined evidence rather than marketing arithmetic.
Failure modes distort the arithmetic when the gate is absent. Production accounts of prior authorization rollouts describe clinical review documentation inconsistent across coordinators, approved authorization codes missing from the record, and denials classified by hand in spreadsheets months after scaling, each a hidden per-case cost that pilots never surfaced. Requiring the gate to examine operational evidence from a shadow period, not just pilot accuracy, is how a payor keeps the per-case promise honest.
Observability keeps the number current after approval. Binding each model request to an approved purpose, an originating identity, and a model route, as payor governance guidance recommends, lets finance compute cost per case by authorized use and spot cases whose handling cost departs from the approved envelope. Variance becomes a gate input: a use case approved as cheap that turns out expensive is drifting in scope, quality, or volume, and each explanation has different risk implications.
Frameworks frame the reporting duty lightly but firmly. The EU AI Act's record-keeping expectations for high-risk systems produce operational logs that per-case accounting can ride on, and a payor gate that captures purpose, identity, route, and volume per request satisfies both the finance question and the documentation duty with the same instrumentation. Cost per case, governed at approval and monitored in production, turns AI economics at payors from an argument into a ledger.
Frequently asked questions
Why is cost per case the right measure for payor AI governance?
Because authorization work is the unit payors actually operate on, with administrative tasks already consuming 34 percent of clinical time. Measuring cost per case forces an approval gate decision to compare claimed savings against governance investment, which runs from USD 40,000 to USD 500,000 for custom software. The healthcare approval gate should require both sides on the record before approval.
How do failed rollouts distort per-case economics?
Production accounts of prior authorization automation describe inconsistent review documentation, approved codes missing from records, and denials classified by hand in spreadsheets after scaling, each adding hidden cost per case that pilots never showed. Requiring the approval gate to examine shadow-period operational evidence, not just pilot accuracy, keeps the healthcare per-case promise honest.
What should the gate record about expected cost per case?
The approval record should state the expected per-case cost of the automated path, the human baseline it replaces, and the volume assumption behind the projection. Payor governance guidance recommends binding each model request to an approved purpose, identity, and route, which lets finance compute actual cost per case by authorized use and feed variances back into the approval gate.
Do framework duties affect per-case cost accounting?
Indirectly, yes. The EU AI Act's record-keeping expectations for high-risk systems produce operational logs, and per-case accounting can ride on those same records without separate instrumentation. For a healthcare payor, aligning the approval gate's cost metadata with framework logging duties means one evidence layer serves finance, oversight, and compliance at once.